NCT00076323View on ClinicalTrials.gov

A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

November 30, 2006

Conditions
Glucosephosphate Dehydrogenase DeficiencyFavism
Interventions
DRUG

Primaquine

Trial Locations (1)

20910

Walter Reed Army Institute of Research, Silver Spring

All Listed Sponsors
lead

Walter Reed Army Institute of Research (WRAIR)

FED

NCT00076323 - A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency | Biotech Hunter | Biotech Hunter